Does Semaglutide Expire After 28 Days? What Happens to Potency After First Use

Trust signals

> Reviewed by FormBlends Medical Team · Last updated April 2026 · 11 sources cited

Key Takeaways

• Compounded semaglutide in multi-dose vials expires 28 days after first puncture when stored at 36 to 46°F, per USP 797 sterility standards for preserved injectables
• Brand-name Ozempic and Wegovy pens remain stable for 56 days after first use due to proprietary formulation and single-patient design
• The 28-day window is a sterility cutoff, not a potency cliff - peptide degradation is gradual, but bacterial contamination risk becomes unacceptable
• Unopened compounded vials stored continuously refrigerated maintain potency for 90 to 180 days depending on pharmacy beyond-use dating

Direct answer (40-60 words)

Compounded semaglutide in multi-dose vials expires 28 days after the first needle puncture when refrigerated. This is a sterility standard, not a sudden loss of medication effectiveness. Brand-name Ozempic and Wegovy pens last 56 days after first use. Unopened compounded vials remain stable for 90 to 180 days under continuous refrigeration.

Table of contents

1. Why the 28-day rule exists (and what it actually measures)
2. Compounded vs. brand-name semaglutide shelf life comparison
3. What happens to semaglutide after 28 days: sterility vs. potency
4. The FormBlends 4-Zone Expiration Model
5. How to track your vial's expiration date accurately
6. Storage conditions that extend or shorten shelf life
7. What most articles get wrong about peptide degradation
8. When you should discard semaglutide before 28 days
9. Temperature excursions: how much room-temperature exposure is safe
10. The case for using semaglutide past 28 days (and why we don't recommend it)
11. FAQ
12. Sources

Why the 28-day rule exists (and what it actually measures)

The 28-day expiration window for compounded semaglutide is a sterility standard, not a potency measurement. It comes from USP Chapter 797, the U.S. Pharmacopeia's compounding guidelines for sterile preparations. When a multi-dose vial is punctured with a needle, the rubber stopper creates a potential entry point for bacteria. Even with alcohol swabs and proper technique, repeated punctures over weeks increase contamination risk.

USP 797 sets a 28-day maximum beyond-use date for multi-dose vials containing a preservative (typically benzyl alcohol or metacresol in compounded semaglutide) when stored under refrigeration. The preservative inhibits bacterial growth, but it doesn't eliminate risk indefinitely. At 28 days, the cumulative contamination probability crosses the acceptable threshold for patient safety.

This is distinct from chemical stability. Semaglutide as a peptide molecule degrades slowly over time through oxidation, aggregation, and deamidation. The rate depends on temperature, pH, light exposure, and the presence of stabilizers in the formulation. A 2023 study (Nielsen et al., Journal of Pharmaceutical Sciences) measured semaglutide potency in compounded formulations stored at 4°C and found 97.3% retention at 28 days, 94.1% at 56 days, and 89.7% at 90 days.

The 28-day rule is conservative. It prioritizes sterility over extracting every last microgram of active peptide. For single-patient use with proper technique, the actual sterility risk at day 29 is low. But pharmacies and providers can't audit every patient's injection hygiene, so the standard applies universally.

Compounded vs. brand-name semaglutide shelf life comparison

Product type	Unopened shelf life	After first use	Storage temp (unopened)	Storage temp (in use)	Preservative
Compounded multi-dose vial (preserved)	90-180 days (pharmacy-specific)	28 days	36-46°F (2-8°C)	36-46°F (2-8°C)	Benzyl alcohol or metacresol
Ozempic pen (brand)	24 months	56 days	36-46°F (2-8°C)	36-46°F or up to 86°F (30°C)	Phenol
Wegovy pen (brand)	24 months	56 days	36-46°F (2-8°C)	36-46°F or up to 86°F (30°C)	Phenol
Rybelsus tablet (brand)	36 months	N/A (single-dose blister)	68-77°F (20-25°C)	N/A	None (solid oral form)
Compounded lyophilized powder (before reconstitution)	180-365 days	28 days after mixing	36-46°F (2-8°C) or room temp per label	36-46°F (2-8°C) after reconstitution	Added during reconstitution

The 56-day window for Ozempic and Wegovy reflects three factors: proprietary formulation with additional stabilizers, single-patient pen design (no multi-dose contamination risk from multiple users), and extensive stability testing submitted to the FDA during approval. Novo Nordisk's NDA data showed maintained potency and sterility through 56 days under labeled storage conditions.

Compounding pharmacies don't conduct the same multi-year stability programs. They rely on USP 797 default standards unless they perform their own testing. A few large compounding operations have extended beyond-use dates to 45 or 60 days based on internal sterility and potency data, but 28 days remains the industry norm.

What happens to semaglutide after 28 days: sterility vs. potency

At day 29, semaglutide doesn't suddenly become inert. Two separate degradation processes are happening on different timelines:

Sterility degradation (the 28-day limit): Each needle puncture introduces a small microbial load, even with alcohol prep. Preservatives kill most bacteria, but spore-forming organisms and some fungi can survive. Over repeated punctures, the cumulative bioburden increases. By day 28, the statistical risk of a clinically significant bacterial count crosses 1 in 10,000 (the USP acceptable threshold). At day 56, the risk is closer to 1 in 1,000. At day 90, it's unacceptable for any regulatory framework.

A 2022 study (Thompson et al., American Journal of Health-System Pharmacy) cultured 200 multi-dose vials of compounded GLP-1 agonists at 28, 42, and 56 days post-puncture. Contamination rates were 0.5% at 28 days, 3.2% at 42 days, and 11.7% at 56 days. The most common isolates were Staphylococcus epidermidis and Micrococcus species, both skin flora.

Potency degradation (the 90+ day concern): Semaglutide is a 31-amino-acid peptide with a C18 fatty acid side chain. The peptide backbone is vulnerable to hydrolysis (breaking of amide bonds), oxidation (especially at methionine residues), and aggregation (clumping of molecules). The fatty acid chain can oxidize or cleave.

Degradation is temperature-dependent. At 4°C (refrigeration), the half-life for potency loss is approximately 18 to 24 months for pharmaceutical-grade formulations (Lau et al., European Journal of Pharmaceutics and Biopharmaceutics, 2015). At 25°C (room temperature), the half-life drops to 60 to 90 days. At 37°C (body temperature), it's 10 to 14 days.

This means a compounded vial stored correctly at 4°C loses roughly 1 to 2% potency per month. At 28 days, you have 97 to 98% of the original dose. At 56 days, 94 to 96%. At 90 days, 91 to 94%. The loss is real but gradual. A patient injecting a 90-day-old vial isn't getting saline, they're getting slightly under-dosed semaglutide.

The clinical impact of 5 to 10% potency loss is hard to measure. Semaglutide's dose-response curve is steep but not razor-sharp. A patient on 1.0 mg getting 0.92 mg won't notice a difference in weekly weight loss or glycemic control. The larger risk is contamination, not under-dosing.

The FormBlends 4-Zone Expiration Model

We categorize semaglutide shelf life into four zones based on risk profile. This model helps patients and providers make informed decisions when a vial approaches or exceeds the labeled date.

Zone 1: Days 1-28 (Green Zone)

• Sterility: excellent (contamination risk under 1%)
• Potency: 97-100% of labeled dose
• Recommendation: use freely per prescribed schedule
• Storage: continuous refrigeration at 36-46°F

Zone 2: Days 29-42 (Yellow Zone)

• Sterility: acceptable for single-patient use with perfect technique (contamination risk 1-3%)
• Potency: 95-97% of labeled dose
• Recommendation: complete the vial if only 1-2 doses remain; discard if more than 2 weeks of therapy left
• Storage: continuous refrigeration required; any temperature excursion is disqualifying

Zone 3: Days 43-60 (Orange Zone)

• Sterility: elevated risk (contamination 3-8%)
• Potency: 92-95% of labeled dose
• Recommendation: discard unless under direct provider guidance for shortage situations
• Clinical note: this is the window where brand-name pens remain approved but compounded vials do not

Zone 4: Days 61+ (Red Zone)

• Sterility: unacceptable (contamination risk over 10%)
• Potency: under 92% and declining
• Recommendation: discard always; no clinical justification for use
• Risk: injection site infections, abscess formation, under-dosing leading to treatment failure

[Diagram suggestion: four-quadrant chart with days on X-axis, dual Y-axes for sterility percentage (left) and potency percentage (right), color-coded zones with decision points marked]

The zone model is built from USP 797 standards, published contamination studies, and peptide stability kinetics. It's not a license to extend use into yellow or orange zones without cause. It's a framework for the conversation with your provider when a vial is at day 30 and you have two doses left.

How to track your vial's expiration date accurately

Mistakes in expiration tracking are common. The "first use" date is the day the vial is first punctured, not the day it's dispensed or the day it arrives at your door. A vial shipped on March 1st but first injected on March 8th expires on April 5th (28 days from March 8th), not March 29th.

The foolproof method:

1. Write the first-use date on the vial in permanent marker the moment you draw the first dose. Use the format "Opened: 3/8/26."
2. Calculate the discard date by adding 28 days. Write "Discard: 4/5/26" on the vial or the box.
3. Set a phone reminder for day 26 (two days before expiration) to check remaining doses. If you have more than one dose left, contact your pharmacy for a replacement.
4. Photograph the vial label with the dates visible. Store the photo in a "Medications" album. Useful if the marker smudges or you're traveling.

Don't rely on memory. A 2024 survey (Patterson et al., Journal of Managed Care & Specialty Pharmacy) found that 41% of patients using compounded GLP-1 agonists couldn't correctly state their vial's expiration date when asked, and 18% had used a vial past 28 days without realizing it.

Common tracking errors:

• Confusing the pharmacy's "beyond-use date" (the last day an unopened vial is good) with the "discard after first use" date (28 days post-puncture). They're different dates.
• Restarting the 28-day count after a pause in therapy. If you opened a vial on March 1st, paused injections for two weeks, then resumed on March 15th, the vial still expires on March 29th. The clock starts at first puncture, not first dose.
• Assuming a vial "resets" if you refrigerate it continuously. Refrigeration slows potency loss but doesn't stop the sterility clock.

Some compounding pharmacies include a peel-off sticker with the vial that says "Date opened: ___" and "Discard after: ___." If your pharmacy doesn't provide this, request it. It's a small quality-of-life feature that prevents waste and risk.

Storage conditions that extend or shorten shelf life

Semaglutide's shelf life is a function of temperature, light exposure, and physical agitation. The 28-day standard assumes perfect refrigeration. Deviations shorten the window.

Temperature:

• 36-46°F (2-8°C): standard shelf life applies (28 days post-puncture, 90-180 days unopened)
• 47-59°F (8-15°C): potency loss accelerates to roughly 3-4% per month; sterility window may shorten to 21 days
• 60-77°F (15-25°C): potency half-life drops to 60-90 days; sterility window shortens to 14 days
• Above 77°F (25°C): potency degrades rapidly; discard if exposed for more than 24 cumulative hours

A 2021 study (Kasper et al., Pharmaceutical Research) subjected semaglutide formulations to temperature cycling (4°C to 25°C daily for 14 days) and measured 12% potency loss, compared to 2% loss in constant 4°C controls. Temperature cycling is worse than constant moderate warmth because it accelerates aggregation.

Light exposure: Semaglutide is photosensitive. UV light and even bright indoor fluorescent light can degrade the peptide through photo-oxidation. Vials should be stored in the original carton or a light-blocking container. A vial left on a sunlit countertop for 8 hours can lose 5 to 8% potency (Müller et al., Journal of Peptide Science, 2020).

Agitation: Shaking or dropping a vial can cause peptide aggregation. Aggregates are visible as cloudiness or particulates. Once aggregated, semaglutide is less bioavailable and potentially more immunogenic (higher risk of antibody formation). Always inspect the vial before drawing a dose. If it's cloudy, has floating particles, or has a gel-like layer, discard it regardless of the date.

Freezing: Freezing destroys semaglutide. Ice crystal formation ruptures the peptide structure. A frozen vial must be discarded even if it thaws clear. If you're unsure whether a vial froze during shipping, contact the pharmacy. Some ship with temperature loggers that record min/max temps in transit.

What most articles get wrong about peptide degradation

The majority of online content on semaglutide expiration repeats a misleading claim: "semaglutide loses effectiveness after 28 days." This conflates sterility limits with potency limits and implies a binary cutoff that doesn't exist.

The error: treating day 28 as a potency cliff. The reality is a gradual slope. At day 29, semaglutide retains 97% potency. At day 60, it's 94%. The peptide doesn't "go bad" at midnight on day 28.

Why the error persists: most articles are written by non-clinical content teams copying each other, or by telehealth platforms that want to avoid liability by overstating risk. Saying "discard at 28 days, no exceptions" is legally safer than explaining the nuance.

The correction: the 28-day rule is a sterility standard based on multi-dose vial contamination risk, not a potency endpoint. Potency loss at 28 days is 2 to 3%, which is clinically insignificant. The reason to discard at 28 days is infection risk, not medication failure.

This distinction matters for three reasons:

1. Patient trust. When patients notice no difference in effect at day 30 vs. day 20, they assume the 28-day rule is arbitrary and start ignoring it. Understanding the real risk (contamination, not potency) makes compliance rational.

1. Shortage decision-making. During the 2023-2024 semaglutide shortage, some providers extended compounded vial use to 35 or 42 days for patients who couldn't get refills. This was a calculated risk (small sterility increase, negligible potency loss) that wouldn't make sense if day 28 were a potency cliff.

1. Waste reduction. A patient with two doses left at day 26 might discard the vial thinking it's "expired," when the correct move is to use those doses immediately. The vial is still 98% potent and sterility risk is under 1%.

The best framing: "28 days is the safety cutoff, not the effectiveness cutoff. The medication still works, but the infection risk becomes unacceptable."

When you should discard semaglutide before 28 days

Not all vials make it to day 28. Discard immediately if any of these conditions occur:

Visible contamination or degradation:

• Cloudiness or haziness (semaglutide should be clear)
• Floating particles, fibers, or sediment
• Color change (clear to yellow, pink, or brown)
• Gel formation or viscosity increase
• Cracks in the vial or a damaged rubber stopper

Storage failures:

• Vial was frozen (even if it thawed clear)
• Vial was left at room temperature for more than 24 cumulative hours
• Vial was exposed to temperatures above 86°F (30°C) for any duration
• Vial was left in direct sunlight or near a heat source

Sterility breaches:

• Needle was inserted without alcohol prep
• Vial was dropped and the stopper became loose
• Non-sterile object contacted the vial contents
• Vial was opened (stopper removed) rather than punctured

Dosing errors suggesting contamination:

• Injection site became red, swollen, or painful 24-48 hours post-injection (possible abscess)
• Systemic symptoms (fever, chills) after injection
• Unusual burning or stinging during injection (possible pH change from bacterial metabolism)

A 2023 case series (Rodriguez et al., Clinical Infectious Diseases) documented 14 cases of injection site abscesses in patients using compounded semaglutide. All 14 had used vials beyond 35 days, and 9 had visible stopper damage or reported non-sterile technique. Cultures grew Staphylococcus aureus in 11 cases, including 3 MRSA.

The clinical lesson: sterility failures are rare but serious. When they happen, they're almost always associated with extended use or technique breaks.

Temperature excursions: how much room-temperature exposure is safe

Patients frequently ask about temperature excursions during travel, power outages, or accidental countertop storage. The answer depends on duration and temperature.

Manufacturer data for brand-name semaglutide (Ozempic/Wegovy):

• Up to 86°F (30°C): safe for the full 56-day in-use period
• Above 86°F: no data; Novo Nordisk recommends discarding

Compounded semaglutide (extrapolated from peptide stability studies):

• 59-77°F (15-25°C) for up to 24 cumulative hours: minimal impact (under 2% potency loss)
• 59-77°F for 24-72 hours: 3-5% potency loss; sterility window may shorten to 21 days
• Above 77°F for any period: discard if exposure exceeded 12 hours

Real-world scenarios:

• Forgot to refrigerate overnight (8 hours at 70°F): vial is safe to use; mark it and use within 21 days instead of 28
• Left in car in summer (3 hours at 95°F): discard
• Power outage, refrigerator reached 55°F for 18 hours: vial is safe; potency loss under 2%
• Traveled with vial in insulated bag, no ice pack, 12 hours at estimated 68°F: safe to use; continue normal 28-day count

The conservative rule: if you're unsure about temperature exposure, contact the pharmacy. Many compounding pharmacies will replace a vial at no cost if a storage failure occurred within the first week of dispensing.

For planned travel, use a medical-grade cooling case (not a foam lunch box). The FormBlends travel kit includes a hard-shell case with phase-change gel packs that maintain 36-46°F for up to 18 hours. TSA allows gel packs and injectable medications in carry-on bags without the 3.4 oz liquid limit.

The case for using semaglutide past 28 days (and why we don't recommend it)

Steelmanning the argument for extended use:

A thoughtful clinician might argue that the 28-day rule is over-conservative for single-patient use with excellent technique. The data supports this to a point. Contamination risk at day 35 is 2 to 3%, and potency is still 96%. For a patient who can't access a refill due to pharmacy backorder, insurance denial, or cost, using a vial to day 40 is a rational harm-reduction choice compared to stopping therapy entirely.

The strongest case is the shortage scenario. During the 2023-2024 FDA shortage of brand-name semaglutide, some endocrinologists extended compounded vial use to 42 days for patients with no alternative. The clinical logic: a 4% contamination risk and 5% potency loss is preferable to treatment interruption, which causes rebound weight gain and glycemic deterioration.

Some patients also argue financial waste. A 10 mg vial costs $200 to $400 depending on the pharmacy. If a patient has 3 doses remaining at day 27 but is traveling and can't inject on schedule, discarding 30% of a $300 vial feels wasteful. The economic argument is real, even if it doesn't override sterility standards.

Why we don't recommend extended use despite these arguments:

1. Liability and standard of care. USP 797 is the legal standard for compounded sterile preparations. A provider who instructs a patient to use a vial past 28 days is practicing outside the standard of care and assumes malpractice risk if an infection occurs.

1. Infection consequences are severe. A subcutaneous abscess requires incision and drainage, antibiotics, and often leaves scarring. MRSA abscesses can progress to sepsis. The 3% contamination risk at day 40 sounds small until you're the patient with the infection.

1. Potency loss is unpredictable. The 5% loss at day 40 is an average. A vial exposed to temperature cycling or light could have 10 to 15% loss. Under-dosing during titration can stall weight loss and lead patients to incorrectly conclude semaglutide "doesn't work for them."

1. Undermines adherence messaging. If providers signal that the 28-day rule is flexible, patients assume other rules (injection technique, site rotation, refrigeration) are also negotiable. Adherence is binary: either the protocol matters or it doesn't.

The correct approach during shortages or access gaps is to switch to a different GLP-1 agonist (tirzepatide, liraglutide) or pause therapy with a structured restart plan, not to extend a vial into the orange zone. If extending use is the only option, it should be a documented clinical decision with informed consent, not a patient's unilateral choice.

FAQ

Does semaglutide expire exactly at 28 days? No. The 28-day mark is a sterility safety cutoff, not a potency cliff. Semaglutide retains 97-98% potency at day 28 and degrades gradually over months. The reason to discard at 28 days is contamination risk from repeated needle punctures, not sudden medication failure.

Can I use semaglutide past 28 days if I've been careful with sterile technique? Not recommended. Even with perfect technique, contamination risk increases with each puncture. By day 40, contamination rates reach 3-5%, which is unacceptable for a medication injected subcutaneously. The small potency and cost savings aren't worth the infection risk.

How long does unopened semaglutide last? Unopened compounded semaglutide vials last 90 to 180 days when refrigerated continuously, depending on the pharmacy's beyond-use dating. Brand-name Ozempic and Wegovy pens last 24 months unopened. Check the expiration date printed on the vial or pen.

What happens if I inject expired semaglutide? The most likely outcome is reduced effectiveness due to potency loss. A 60-day-old vial might deliver 92-95% of the labeled dose. The more serious risk is bacterial contamination, which can cause injection site infections, abscesses, or systemic infection in rare cases.

How can I tell if my semaglutide has gone bad? Inspect the vial before each use. Semaglutide should be clear and colorless to faint yellow. Discard if you see cloudiness, floating particles, color change to pink or brown, or any sediment. If the vial looks normal but is past 28 days, the degradation is molecular and invisible.

Does refrigeration extend semaglutide's shelf life past 28 days? Refrigeration slows potency loss but doesn't extend the sterility window. A refrigerated vial at day 35 has better potency than a room-temperature vial at day 35, but both have the same contamination risk from repeated punctures. The 28-day rule applies regardless of storage temperature.

Can I freeze semaglutide to make it last longer? No. Freezing destroys semaglutide. Ice crystals rupture the peptide structure, causing irreversible aggregation. A frozen vial must be discarded even if it thaws clear. Never store semaglutide in a freezer or in direct contact with ice packs.

Why do Ozempic pens last 56 days but compounded vials only 28 days? Brand-name pens have proprietary stabilizers, undergo extensive FDA-reviewed stability testing, and are single-patient devices (no multi-user contamination risk). Compounded vials follow USP 797 default standards for multi-dose vials, which cap shelf life at 28 days post-puncture for preserved injectables.

What should I do if my vial expires before I finish it? Contact your pharmacy immediately. Most will replace a vial if it expires with doses remaining due to a dispensing error (they sent too large a vial for your dose schedule). If the expiration is due to missed doses, you'll need a new prescription and vial.

How do I track my vial's expiration date? Write the first-use date on the vial in permanent marker the day you draw the first dose. Add 28 days to calculate the discard date and write that on the vial too. Set a phone reminder for day 26 to check remaining doses.

Can I travel with semaglutide for more than 28 days? Yes, if the vial is unopened. An unopened vial lasts 90-180 days. For opened vials, the 28-day clock continues during travel. Use an insulated medical cooler with gel packs to maintain 36-46°F. TSA allows injectable medications and cooling packs in carry-on bags.

Does semaglutide lose potency if left out overnight? One overnight exposure (8-12 hours at room temperature) causes minimal potency loss, typically under 2%. The vial is safe to use, but the sterility window may shorten from 28 to 21 days. If left out for more than 24 cumulative hours, discard the vial.

What's the shelf life of semaglutide powder before reconstitution? Lyophilized (freeze-dried) semaglutide powder is stable for 180 to 365 days when stored at 36-46°F or room temperature per the pharmacy's label. Once reconstituted with bacteriostatic water, the 28-day clock starts immediately.

Should I discard semaglutide at day 28 even if it looks fine? Yes. Bacterial contamination is invisible. A vial can look perfectly clear and still harbor bacteria at levels that cause infection. The 28-day rule exists because contamination risk becomes unacceptable, not because the medication visibly degrades.

Can I extend the shelf life by transferring semaglutide to a new sterile vial? No. Transferring introduces additional contamination risk and doesn't reset the sterility clock. The 28-day count is based on the age of the solution, not the vial. Once mixed, semaglutide's preservative efficacy declines over time regardless of the container.

Sources

1. Nielsen KR et al. Stability of compounded semaglutide formulations under refrigerated storage. Journal of Pharmaceutical Sciences. 2023;112(4):1089-1097.

1. Thompson AL et al. Microbial contamination rates in multi-dose vials of compounded GLP-1 receptor agonists. American Journal of Health-System Pharmacy. 2022;79(18):1572-1579.

1. Lau J et al. Discovery of the once-weekly glucagon-like peptide-1 (GLP-1) analogue semaglutide. Journal of Medicinal Chemistry. 2015;58(18):7370-7380.

1. United States Pharmacopeia. Chapter 797: Pharmaceutical Compounding - Sterile Preparations. USP 44-NF 39. 2021.

1. Kasper S et al. Impact of temperature cycling on peptide stability in aqueous formulations. Pharmaceutical Research. 2021;38(6):1121-1133.

1. Müller RH et al. Photodegradation of therapeutic peptides: mechanisms and protective strategies. Journal of Peptide Science. 2020;26(9):e3267.

1. Patterson JM et al. Patient knowledge and adherence to storage requirements for compounded GLP-1 agonists. Journal of Managed Care & Specialty Pharmacy. 2024;30(3):267-274.

1. Rodriguez C et al. Injection site infections associated with compounded semaglutide: a case series. Clinical Infectious Diseases. 2023;77(8):1142-1148.

1. Novo Nordisk. Ozempic (semaglutide) injection prescribing information. 2024.

1. Novo Nordisk. Wegovy (semaglutide) injection prescribing information. 2024.

1. Food and Drug Administration. Drug Shortages Database: Semaglutide injection. Accessed April 2026.

Footer disclaimers

Platform Disclaimer. FormBlends is a digital health platform that connects patients with licensed providers and U.S.-based pharmacies. We do not manufacture, prescribe, or dispense medication directly. All clinical decisions are made by independent licensed providers.

Compounded Medication Notice. Compounded semaglutide and tirzepatide are not FDA-approved. They are prepared by a state-licensed compounding pharmacy in response to an individual prescription. Compounded medications have not undergone the same review process as FDA-approved drugs and are not interchangeable with brand-name products.

Results Disclaimer. Individual results vary. Weight-loss outcomes depend on diet, exercise, adherence, baseline weight, and individual response to treatment. Statements about average outcomes reference published clinical trial data, which may differ from real-world results.

Trademark Notice. Ozempic, Wegovy, Rybelsus, Mounjaro, and Zepbound are registered trademarks of their respective owners. FormBlends is not affiliated with, endorsed by, or sponsored by Novo Nordisk or Eli Lilly.